49 Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$213K Buy
+4,879
New +$226K 0.01% 208
2026
Q1
– Sell
-2,404
Closed -$229K – 211
2025
Q4
$229K Hold
2,404
– – 0.02% 176
2025
Q3
$235K Sell
2,404
-12
-0.5% -$1.24K 0.02% 169
2025
Q2
$260K Sell
2,416
-21
-0.9% -$2.12K 0.03% 145
2025
Q1
$246K Hold
2,437
– – 0.03% 154
2024
Q4
$218K Sell
2,437
-51
-2% -$4.49K 0.03% 150
2024
Q3
$208K Buy
+2,488
New +$196K 0.03% 157

Other funds holding BSX

49 Wealth Management's BSX Position: Q3 2026 in Review

49 Wealth Management opened a new position in Boston Scientific (BSX) in Q3 2026: 4,879 shares worth $213K. The stake represents 0.01% of the portfolio and ranks #208 among its holdings. This is a return to the name: 49 Wealth Management previously reported a position in BSX as recently as Q4 2025.

49 Wealth Management first reported a position in BSX in Q3 2024 and has held it in 7 quarters since. The position peaked at $260K in Q2 2025. 1,516 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • 49 Wealth Management held 4,879 shares of Boston Scientific worth $213K as of Q3 2026.
  • Boston Scientific was a new 49 Wealth Management position in Q3 2026.
  • Boston Scientific made up 0.01% of 49 Wealth Management's portfolio in Q3 2026, its #208 holding.
  • 49 Wealth Management first reported a position in Boston Scientific in Q3 2024 and has held it in 7 quarters since.
  • 49 Wealth Management's Boston Scientific position peaked at $260K in Q2 2025.
  • 1,516 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on 49 Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.